Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 54 out of 100. Prevention and risk

Topic: Risk, prevention and care in population studies

Plain-language summary

Results Of 3424 articles on potentially modifiable risk factors for dementia, 1719 met our inclusion criteria; 60 were deemed to be of good or fair quality. More importantly, there are few data to explain the overall risks and benefits of prevention strategies or their impact of risk modification.

What this study adds

Evidence grade: Moderate

This is a follow-up (cohort) study. This review of articles on potentially modifiable dementia risk factors found few data to explain the overall risks and benefits of prevention strategies. It does not identify any proven way to prevent Alzheimer's disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Patterson, C., Feightner, J. W., Garcia, A., Hsiung, G. Y., MacKnight, C., & Sadovnick, A. D. (2008). Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. https://doi.org/10.1503/cmaj.070796

Vancouver

Patterson C, Feightner JW, Garcia A, Hsiung GY, MacKnight C, Sadovnick AD. Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne. 2008. doi:10.1503/cmaj.070796. PMID: 18299540.

BibTeX

@article{patterson2008-18299540,
  author  = {Patterson, C. and Feightner, J. W. and Garcia, A. and Hsiung, G. Y. and MacKnight, C. and Sadovnick, A. D.},
  title   = {{Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease}},
  journal = {CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
  year    = {2008},
  doi     = {10.1503/cmaj.070796},
  pmid    = {18299540},
  url     = {https://doi.org/10.1503/cmaj.070796}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

This review of articles on potentially modifiable dementia risk factors found few data to explain the overall risks and benefits of prevention strategies. It does not identify any proven way to prevent Alzheimer's disease.

Study details

How this study scored 54/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record left out, no data; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 10 of 10; How recent 1 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 5 of 7; Citations per year 3 of 5; Impact for its field and year 4 of 6; Cited by studies here 1 of 6; Still being cited 2 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multicenter collaboration 3 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. 52 of the 96 points it could be judged on, which is 54 of 100. Total 54 of 100.52 of the 96 points we could judge = 54 of 100

Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on journal's citation record, so that was left out: it earned 52 of the 96 points we could judge it on, which is 54 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne)
Journal's citation record — / 4 No journal record from OpenAlex — left out of this score
Study design 7 / 12 A cohort study following people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 1 / 5 2008 — within 20 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 5 / 7 Cited 269 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 13.4 citations a year over 20 year(s) since 2008
Impact for its field and year 4 / 6 Cited 19.5× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 2 other studies in this library
Still being cited 2 / 4 Cited 20 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Adele Dessa Sadovnick: h-index 80 (OpenAlex, whole career)
Institution's track record 1 / 3 University of British Columbia: institution h-index 1,424 (OpenAlex)
Multicenter collaboration 3 / 3 OpenAlex lists 10 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 18299540)
Free to read 0 / 2 Behind a paywall — scores zero
Points 52 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 52 of the 96 points we could judge it on is 54 out of 100.
Total 54 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 29.

Later studies that cite this one

2 studies in the alzhub library list this one in their references.

Related studies in Prevention and risk from nearby years

Also tagged “prevalence”

1,225 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,225 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Prevention and risk

See all studies in Prevention and risk →